Posted by Michael Wonder on 03 Sep 2019
As Congress considers lowering drug costs, pharma CEOs target key senators with campaign cash
3 September 2019 - Top pharmaceutical CEOs have targeted a small group of Republican senators with roughly $200,000 in campaign donations in the past year, according to a STAT review of campaign finance disclosures.
The focus on Congress comes as drug executives are holding back on donations to presidential candidates.
No major industry executive has contributed to a Democratic presidential contender or President Trump’s reelection campaign, according to the review.
